Australian clinical-stage biopharmaceutical company ENA Respiratory has been awarded an additional US$3.18 million contract from the US Department of Defense. …
ENA respiratory secures extension of US funding for novel prophylactic antiviral
September 8, 2024 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
Immutep says it candidate in combination with Keytruda delivered positive efficacy and safety profile
September 16, 2024 - - Latest News -
Medicines Australia responds to questions on the HTA Review
September 16, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number two of five
September 16, 2024 - - Latest News -
Australian company Kazia executes licensing agreement with QIMR Berghofer
September 16, 2024 - - Latest News -
A statement with intent that limits expectations and frames reform as a one-sided trade-off
September 16, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number one of five
September 16, 2024 - - Latest News -
Pharmac announces plan to deploy more of its recent funding boost
September 16, 2024 - - Latest News